Rivaroxaban for the treatment of superficial vein thrombosis, experience at King's College Hospital

Affiliations

¹ King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
² Institute of Pharmaceutical Sciences, King's College London, London, UK.

Rachel E Clapham et al. Br J Haematol. 2022 Jan.

. 2022 Jan;196(1):e3-e6.

doi: 10.1111/bjh.17757. Epub 2021 Aug 5.

¹ King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
² Institute of Pharmaceutical Sciences, King's College London, London, UK.

No abstract available

Keywords: anticoagulants; factor Xa inhibitor; rivaroxaban; superficial vein thrombosis.

References

1. Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev. 2018; 2: CD004982.
1. Frappé P, Buchmuller-Cordier A, Bertoletti L, Bonithon-Kopp C, Couzan S, Lafond P, et al. Annual diagnosis rate of superficial vein thrombosis of the lower limbs: the STEPH community-based study. J Thromb Haemost. 2014;12(6):831-8.
1. Decousus H, Frappé P, Accassat S, Bertoletti L, Buchmuller A, Seffert B, et al. Epidemiology, diagnosis, treatment and management of superficial-vein thrombosis of the legs. Best Pract Res Clin Haematol. 2012;25(3):275-84.
1. Scott G, Mahdi AJ, Alikhan R. Superficial vein thrombosis: a current approach to management. Br J Haematol. 2015;168:639-45.
1. Di Minno MND, Ambrosino P, Ambrosini F, Tremoli E, Di Minno G, Dentali F. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis. J Thromb Haemost. 2016;14:964-72.